Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer (Q36381459)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

title

Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Stephen P. Pereira

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

2

Steven W M Olde Damink

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

author name string

Dipok Kumar Dhar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

James Hal Brindley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Andrew Godfrey

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Michael H Chapman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Neomal S Sandanayake

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Sybille Mazurek

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Tayyaba Hasan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

Massimo Malago

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

language of work or name

English

0 references

publication date

1 August 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

page(s)

575-585

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model

10 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Identification of small molecule inhibitors of pyruvate kinase M2

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Antigen presentation by dendritic cells in tumors is disrupted by altered metabolism that involves pyruvate kinase M2 and its interaction with SOCS3.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Differential behavior of missense mutations in the intersubunit contact domain of the human pyruvate kinase M2 isozyme

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Regulation of M2-type pyruvate kinase mediated by the high-affinity IgE receptors is required for mast cell degranulation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Pyruvate kinase M2 is a phosphotyrosine-binding protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Trends in the incidence of primary liver and biliary tract cancers in England and Wales 1971-2001

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Serum and bile markers for cholangiocarcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Proteome analysis of hepatocellular carcinoma cell strains, MHCC97-H and MHCC97-L, with different metastasis potentials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Regulation of glycolysis by Raf protein serine/threonine kinases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

TUM2-PK (pyruvate kinase type tumor M2), CA19-9 and CEA in patients with benign, malignant and metastasizing pancreatic lesions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Identification of osteopontin as the most consistently over-expressed gene in intrahepatic cholangiocarcinoma: detection by oligonucleotide microarray and real-time PCR analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.

28 June 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27611

Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27611

Clinical significance of serum tumour M2-PK and CA19-9 detection in the diagnosis of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27611

Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27611

Pyruvate kinase type tumor M2 plasma levels in patients afflicted with rheumatic diseases.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3492546

Polytrauma induces increased expression of pyruvate kinase in neutrophils

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22864959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative studies of DU-PAN-2, carcinoembryonic antigen, and CA19-9 in the serum and bile of patients with pancreatic and biliary tract diseases: evaluation of the influence of obstructive jaundice

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22864959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increased mast cells in hepatocellular carcinoma and intrahepatic cholangiocarcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22864959

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1002/CNCR.27611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22864959%20AND%20SRC:MED&resulttype=core&format=json

10 February 2020

1 reference